IRadimed Corp (IRMD) stock
IRMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3060% above fair value
$85.35+0.12 (+0.14%)
Close on Nov 13, 2026Market cap $1.09BP/E 45.6Yield –
IRadimed total assets
Total assets on the balance sheet at the end of each period.
IRadimed's total assets was $121.07M at Sep 30, 2026. For fiscal 2025 it was $108.78M, up 10.6% from the year before. Over ten years it grew 11.9% a year on average. The highest annual figure on record is $108.78M in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $108.78M | +10.6% |
| FY2024 | Dec 31, 2024 | $98.33M | +6.7% |
| FY2023 | Dec 31, 2023 | $92.16M | +7.8% |
| FY2022 | Dec 31, 2022 | $85.51M | +3.2% |
| FY2021 | Dec 31, 2021 | $82.88M | +16.6% |
| FY2020 | Dec 31, 2020 | $71.07M | +6.5% |
| FY2019 | Dec 31, 2019 | $66.73M | +37.7% |
| FY2018 | Dec 31, 2018 | $48.44M | +24.2% |
| FY2017 | Dec 31, 2017 | $39.01M | +4.9% |
| FY2016 | Dec 31, 2016 | $37.19M | +5.5% |
| FY2015 | Dec 31, 2015 | $35.24M | +51.2% |
| FY2014 | Dec 31, 2014 | $23.31M | +233.6% |
| FY2013 | Dec 31, 2013 | $6.99M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $121.07M | +5.5% |
| Q2 FY2026 | Jun 30, 2026 | $114.98M | +8.0% |
| Q1 FY2026 | Mar 31, 2026 | $114.39M | +12.4% |
| Q4 FY2025 | Dec 31, 2025 | $108.78M | +10.6% |
| Q3 FY2025 | Sep 30, 2025 | $114.72M | +21.7% |
| Q2 FY2025 | Jun 30, 2025 | $106.45M | +18.3% |
| Q1 FY2025 | Mar 31, 2025 | $101.73M | +15.6% |
| Q4 FY2024 | Dec 31, 2024 | $98.33M | +6.7% |
| Q3 FY2024 | Sep 30, 2024 | $94.25M | +7.8% |
| Q2 FY2024 | Jun 30, 2024 | $89.95M | +10.5% |
| Q1 FY2024 | Mar 31, 2024 | $88.01M | +16.4% |
| Q4 FY2023 | Dec 31, 2023 | $92.16M | +7.8% |
| Q3 FY2023 | Sep 30, 2023 | $87.41M | +9.9% |
| Q2 FY2023 | Jun 30, 2023 | $81.43M | +7.5% |
| Q1 FY2023 | Mar 31, 2023 | $75.62M | +4.5% |
| Q4 FY2022 | Dec 31, 2022 | $85.51M | +3.2% |
| Q3 FY2022 | Sep 30, 2022 | $79.54M | +1.5% |
| Q2 FY2022 | Jun 30, 2022 | $75.72M | +0.2% |
| Q1 FY2022 | Mar 31, 2022 | $72.39M | +0.3% |
| Q4 FY2021 | Dec 31, 2021 | $82.88M | +16.6% |
| Q3 FY2021 | Sep 30, 2021 | $78.40M | +11.3% |
| Q2 FY2021 | Jun 30, 2021 | $75.58M | +9.8% |
| Q1 FY2021 | Mar 31, 2021 | $72.19M | +5.6% |
| Q4 FY2020 | Dec 31, 2020 | $71.07M | +6.5% |
| Q3 FY2020 | Sep 30, 2020 | $70.43M | +12.6% |
| Q2 FY2020 | Jun 30, 2020 | $68.82M | +21.1% |
| Q1 FY2020 | Mar 31, 2020 | $68.37M | +25.6% |
| Q4 FY2019 | Dec 31, 2019 | $66.73M | +37.7% |
| Q3 FY2019 | Sep 30, 2019 | $62.57M | +33.7% |
| Q2 FY2019 | Jun 30, 2019 | $56.84M | +32.7% |
| Q1 FY2019 | Mar 31, 2019 | $54.41M | +35.2% |
| Q4 FY2018 | Dec 31, 2018 | $48.44M | +24.2% |
| Q3 FY2018 | Sep 30, 2018 | $46.81M | +23.4% |
| Q2 FY2018 | Jun 30, 2018 | $42.83M | +16.3% |
| Q1 FY2018 | Mar 31, 2018 | $40.26M | +7.6% |
| Q4 FY2017 | Dec 31, 2017 | $39.01M | +4.9% |
| Q3 FY2017 | Sep 30, 2017 | $37.92M | – |
| Q2 FY2017 | Jun 30, 2017 | $36.84M | – |
| Q1 FY2017 | Mar 31, 2017 | $37.42M | – |
| Q4 FY2016 | Dec 31, 2016 | $37.19M | – |
See a number that looks wrong?